Cite
Vittone F, Chait A, Morse JS, et al. Niacin plus Simvastatin Reduces Coronary Stenosis Progression Among Patients with Metabolic Syndrome Despite a Modest Increase in Insulin Resistance: A Subgroup Analysis of the HDL-Atherosclerosis Treatment Study (HATS). J Clin Lipidol. 2007;1(3):203-210doi: 10.1016/j.jacl.2007.05.003.
Vittone, F., Chait, A., Morse, J. S., Fish, B., Brown, B. G., & Zhao, X. Q. (2007). Niacin plus Simvastatin Reduces Coronary Stenosis Progression Among Patients with Metabolic Syndrome Despite a Modest Increase in Insulin Resistance: A Subgroup Analysis of the HDL-Atherosclerosis Treatment Study (HATS). Journal of clinical lipidology, 1(3), 203-210. https://doi.org/10.1016/j.jacl.2007.05.003
Vittone, Francesca, et al. "Niacin plus Simvastatin Reduces Coronary Stenosis Progression Among Patients with Metabolic Syndrome Despite a Modest Increase in Insulin Resistance: A Subgroup Analysis of the HDL-Atherosclerosis Treatment Study (HATS)." Journal of clinical lipidology vol. 1,3 (2007): 203-210. doi: https://doi.org/10.1016/j.jacl.2007.05.003
Vittone F, Chait A, Morse JS, Fish B, Brown BG, Zhao XQ. Niacin plus Simvastatin Reduces Coronary Stenosis Progression Among Patients with Metabolic Syndrome Despite a Modest Increase in Insulin Resistance: A Subgroup Analysis of the HDL-Atherosclerosis Treatment Study (HATS). J Clin Lipidol. 2007 Jul;1(3):203-210. doi: 10.1016/j.jacl.2007.05.003. PMID: 18591993; PMCID: PMC2157569.
Copy
Download .nbib
